Forbes William P
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Forbes William P. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| HRTX | EVP, Chief Development Officer | Option Exercise | 11,694 | — | — | Oct 31, 2025 |
| HRTX | EVP, Chief Development Officer | Option Exercise | 3,874 | — | — | Oct 19, 2025 |
| HRTX | EVP, Chief Development Officer | Option Exercise | 11,695 | — | — | Jul 31, 2025 |
| HRTX | EVP, Chief Development Officer | Option Exercise | 3,874 | — | — | Jul 19, 2025 |
| HRTX | EVP, Chief Development Officer | Option Exercise | 12,500 | — | — | Jun 6, 2025 |
| HRTX | EVP, Chief Development Officer | Option Exercise | 11,694 | — | — | Apr 30, 2025 |
| HRTX | EVP, Chief Development Officer | Option Exercise | 3,875 | — | — | Apr 19, 2025 |
| HRTX | EVP, Chief Development Officer | Option Exercise | 3,874 | — | — | Jan 19, 2025 |
| HRTX | EVP, Chief Development Officer | Option Exercise | 3,874 | — | — | Oct 19, 2024 |
| HRTX | EVP, Chief Development Officer | Option Exercise | 3,875 | — | — | Jul 19, 2024 |
| HRTX | EVP, Chief Development Officer | Option Exercise | 12,500 | — | — | Jun 6, 2024 |
| HRTX | EVP, Chief Development Officer | Option Exercise | 3,874 | — | — | Apr 19, 2024 |
| HRTX | EVP, Chief Development Officer | Purchase | 25,000 | $1.09 | $27,250 | Nov 17, 2023 |
| HRTX | EVP, Chief Development Officer | Purchase | 50,000 | $0.94 | $47,000 | Nov 16, 2023 |
| XAIR | Purchase | 5,000 | $6.67 | $33,350 | Mar 31, 2023 | |
| XAIR | Purchase | 5,000 | $6.46 | $32,300 | Mar 17, 2023 | |
| XAIR | Purchase | 4,855 | $5.15 | $25,003 | Jun 3, 2019 | |
| 0001009356 | President, Medical, R&D & CDO | Disposition | 51,714 | $173.00 | $8,946,522 | Apr 1, 2015 |
| 0001009356 | President, Medical R&D and CDO | Sale | 42,880 | $157.84 | $6,768,179 | Mar 9, 2015 |
| 0001009356 | EVP Research&Devel & CDO | Sale | 20,000 | $157.96 | $3,159,200 | Mar 6, 2015 |
| 0001009356 | EVP Research&Devel & CDO | Tax Withholding | 10,997 | $114.94 | $1,263,995 | Jan 2, 2015 |
| 0001009356 | EVP Research&Devel & CDO | Sale | 11,079 | $95.05 | $1,053,059 | Nov 12, 2014 |
| 0001009356 | EVP Research&Devel & CDO | Award / Grant | 19,809 | $158.30 | $3,135,765 | Aug 22, 2014 |
| 0001009356 | EVP Research&Devel & CDO | Tax Withholding | 1,971 | $123.35 | $243,123 | Jul 1, 2014 |
| 0001009356 | EVP Research&Devel & CDO | Award / Grant | 19,809 | $100.66 | $1,993,974 | Apr 17, 2014 |
| 0001009356 | EVP Research&Devel & CDO | Sale | 8,000 | $90.06 | $720,480 | Jan 8, 2014 |
| 0001009356 | EVP Research&Devel & CDO | Tax Withholding | 8,851 | $89.94 | $796,059 | Jan 2, 2014 |
| 0001009356 | EVP Research&Devel & CDO | Sale | 3,000 | $69.91 | $209,730 | Jul 24, 2013 |
| 0001009356 | EVP Research&Devel & CDO | Tax Withholding | 4,835 | $66.15 | $319,835 | Jul 1, 2013 |
| 0001009356 | EVP Research&Devel & CDO | Award / Grant | 23,741 | $48.70 | $1,156,187 | Apr 18, 2013 |
| 0001009356 | EVP Research&Devel & CDO | Sale | 8,673 | $49.37 | $428,186 | Apr 10, 2013 |
| 0001009356 | EVP Research&Devel & CDO | Tax Withholding | 5,052 | $40.47 | $204,454 | Jan 2, 2013 |
| 0001009356 | EVP Research&Devel & CDO | Tax Withholding | 4,107 | $54.44 | $223,585 | Jul 2, 2012 |
| 0001009356 | EVP Research&Devel & CDO | Sale | 7,100 | $51.35 | $364,585 | May 8, 2012 |
| 0001009356 | EVP Research&Devel & CDO | Award / Grant | 20,713 | — | — | Apr 25, 2012 |
| 0001009356 | EVP Research&Devel & CDO | Sale | 4,297 | $50.00 | $214,850 | Feb 13, 2012 |
| 0001009356 | EVP Research&Devel & CDO | Option Exercise | 259 | $17.53 | $4,540 | Feb 3, 2012 |
| 0001009356 | EVP Research&Devel & CDO | Sale | 125 | $50.00 | $6,250 | Jan 17, 2012 |
| 0001009356 | EVP Research&Devel & CDO | Tax Withholding | 2,506 | $47.85 | $119,912 | Jan 3, 2012 |
| 0001009356 | EVP Research&Devel & CDO | Sale | 13,000 | $39.60 | $514,800 | Jul 7, 2011 |
| 0001009356 | EVP Research&Devel & CDO | Tax Withholding | 9,212 | $39.83 | $366,914 | Jul 1, 2011 |
| 0001009356 | EVP Research&Devel & CDO | Sale | 20,000 | $40.35 | $807,000 | May 16, 2011 |
| 0001009356 | V.P. Research& Devel & CDO | Award / Grant | 22,698 | — | — | Apr 25, 2011 |
| 0001009356 | V.P. Research& Devel & CDO | Option Exercise | 10,000 | $17.53 | $175,300 | Nov 10, 2010 |
| 0001009356 | V.P. Research& Devel & CDO | Sale | 10,695 | $40.50 | $433,148 | Sep 15, 2010 |
| 0001009356 | V.P. Research& Devel & CDO | Award / Grant | 15,055 | — | — | Jul 19, 2010 |
| 0001009356 | V.P. Research& Devel & CDO | Tax Withholding | 7,586 | $39.03 | $296,082 | Jul 1, 2010 |
| 0001009356 | V.P. Research& Devel & CDO | Sale | 10,000 | $40.03 | $400,300 | Apr 14, 2010 |
| 0001009356 | V.P. Research& Devel & CDO | Sale | 1,879 | $38.00 | $71,402 | Apr 1, 2010 |
| 0001009356 | V.P. Research& Devel & CDO | Sale | 5,000 | $25.00 | $125,000 | Dec 23, 2009 |